MCL-135 BRUIN MCL-321, a Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Investigator Choice of BTK Inhibitor in Patients With Previously Treated, BTK Inhibitor Naïve Mantle Cell Lymphoma (Trial in Progress)
作者
Rodrigo Ito,Toby Andrew Eyre,Nirav Niranjan Shah,Steven Le Gouill,Martin H. Dreyling,Elisabeth Vandenberghe,Wojciech J. Jurczak,Yucai Wang,Chan Yoon Cheah,Mitul D. Gandhi,Christopher H. Chay,Jeff Porter Sharman,David Jacob Andorsky,Yuqin Song,Amy Stark,Valerie Muthig,Michael L. Wang